Pathogenesis (development of disease)
The common pathway for the development of quincke’s edema (angioedema) is activation of the bradykinin pathway. This peptide is a potent vasodilator that leads to rapidly developing edema in the interstitium: According to the cause, the following forms of Quincke’s edema (angioedema) are distinguished:
- Histamine-mediated angioedema.
- Allergic angioedema; occurs in half of cases in association with urticaria (hives); most common form
- Allergy-like angioedema – in the context of infections, intolerances (intolerance reactions; usually triggered by drugs such as acetylsalicylic acid (ASA) or autoimmune reactions (pathological (pathological) reaction of the immune system against the body’s own tissue).
- Physical-conditional: e.g., pressure, cold, light, etc.
- Idiopathic angioedema – without apparent cause (rare).
- Bradykinin-mediated angioedema (bradykinin is a peptide and tissue hormone that is, among other things, vasoactive (blood vessel altering) and involved in pain production).
- Hereditary angioedema (HAE) – due to C1 esterase inhibitor (C1-INH) deficiency (blood protein deficiency); approximately 6% of cases:
- Type 1 (85% of cases) – decreased activity and concentration of C1 inhibitor; autosomal dominant inheritance (new mutations about 25% of cases).
- Type II (15% of cases) – decreased activity with normal or increased concentration of C1 inhibitor.
De novo mutations account for approximately 10-20% of cases.
- RAAS inhibitor-induced angioedema (RAE) – caused by cardiovascular medications: ACE inhibitors (ACE inhibitor (ACEi); common) or AT1 antagonists (angiotensin II receptor subtype 1 antagonists, AT1 receptor antagonists, AT1 blockers, angiotensin receptor blockers, “sartans“) (rare).
- Acquired angioedema:
- Especially in malignant lymphoma (colloquially lymph node cancer) (type 1) or
- C1 inhibitor antibodies (type 2).
- Hereditary angioedema (HAE) – due to C1 esterase inhibitor (C1-INH) deficiency (blood protein deficiency); approximately 6% of cases:
- Other angioedema – the development cannot be explained by histamine alone, nor by bradykinin alone; other endogenous substances play a role here.
Etiology (causes)
Biographical causes
- Genetic burden
- By parents, grandparents
- C1 inhibitor gene mutations (HAE-C1-INH/hereditary angioedema (HAE) with C1 inhibitor mutation).
- Hereditary angioedema type 3 – point mutation in a gene encoding blood coagulation factor XII (Hagemann factor; factor XII).
-
Bradykinin-induced angioedema/HAE-C1-INH (type 1/type 2).
- Bradykinin-induced angioedema: factor XII mutations (HAE-FXII), plasminogen mutation (HAE-PLG).
- Other/unclear etiologies: Angiopoietin-1 mutation (HAE-ANGPT1), unknown mutations (HAE-UNK).
- Spring-born (possibly due toearly contact with inhaled allergens (especially pollen)).
Behavioral causes
- Physical activity
- Physical exertion [trigger of acute HAE attacks].
- Psycho-social situation
- Stress [trigger of acute HAE attacks]
Disease-related causes (including triggers for HAE attacks).
Endocrine, nutritional, and metabolic diseases (E00-E90).
- C1 esterase deficiency – glycoprotein from the serine protease inhibitor group, which has a regulatory effect in the complement system (defense system).
Infectious and parasitic diseases (A00-B99).
- Infectious diseases, unspecified
Neoplasms – tumor diseases (C00-D48).
- Malignant lymphoma – malignant neoplasm of the lymphatic system.
Injuries, poisoning, and other consequences of external causes (S00-T98).
- Allergic reactions, unspecified
- Taumata [trigger of acute HAE attacks]
Medication
- ACE inhibitors (antihypertensives) [>50% of cases with severe angioedema; trigger of acute HAE attacks]
- Acetylsalicylic acid (ASA).
- Angiotensin receptor neprilysin antagonists (ARNI) – dual drug combination: sacubitril/valsartan.
- AT1 antagonists (angiotensin II receptor subtype 1 antagonists, AT1 receptor antagonists, AT1 blockers, angiotensin receptor blockers, “sartans”) (rare)
- Hormone replacement therapy (HRT)
- Non-steroidal anti-inflammatory drugs (NSAIDs)
- Estrogen-containing contraceptives – these can cause attacks to cluster [trigger acute HAE attacks].
- X-ray contrast media (as an immediate response).
Operations
- Surgeries including dental procedures [triggers of acute HAE attacks].
Other causes
- Menstruation (menstrual period) [trigger of acute HAE attacks]; ovulation (ovulation).
- Physical – pressure, cold, light, etc.
- Psychological stress situations
- Pregnancy